Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of paclitaxel and everolimus-eluting stents in ST-segment elevation myocardial infarction and influence of thrombectomy on outcomes. ESTROFA-IM study.
de la Torre Hernández JM, Alfonso F, Martin Yuste V, Sánchez Recalde A, Jimenez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, García Camarero T, Elizaga J, Calviño R, Moreu J, Bosa F, Jimenez Mazuecos J, Ruiz-Arroyo JR, Garcia Del Blanco B, Rumoso JR; ESTROFA-IM study group. de la Torre Hernández JM, et al. Among authors: sanchez recalde a. Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):999-1006. doi: 10.1016/j.rec.2014.01.019. Epub 2014 Jun 7. Rev Esp Cardiol (Engl Ed). 2014. PMID: 25432710
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation.
Moreno R, Fernandez C, Sanchez-Recalde A, Galeote G, Calvo L, Alfonso F, Hernandez R, Sánchez-Aquino R, Angiolillo DJ, Villarreal S, Macaya C, Lopez-Sendon JL. Moreno R, et al. Among authors: sanchez aquino r, sanchez recalde a. Eur Heart J. 2007 Jul;28(13):1583-91. doi: 10.1093/eurheartj/ehl423. Epub 2007 Feb 8. Eur Heart J. 2007. PMID: 17289741
A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated by EveroLimus-Eluting Stent) trial.
Moreno R, Garcia E, Teles RC, Almeida MS, Carvalho HC, Sabate M, Martin-Reyes R, Rumoroso JR, Galeote G, Goicolea FJ, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Perez de Prado A, Martin-Yuste V, Jimenez-Valero S, Sanchez-Recalde A, Calvo L, Lopez de Sa E, Macaya C, Lopez-Sendon JL. Moreno R, et al. Among authors: sanchez recalde a. EuroIntervention. 2010 May;6(1):112-6. EuroIntervention. 2010. PMID: 20542806 Clinical Trial.
Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents.
Moreno R, Jimenez-Valero S, Sanchez-Recalde A, Galeote G, Calvo L, Martin-Reyes R, Sabate M, Plaza I, Macaya C, Lopez-Sendon JL. Moreno R, et al. Among authors: sanchez recalde a. EuroIntervention. 2011 Mar;6(8):1003-10. doi: 10.4244/EIJV6I8A173. EuroIntervention. 2011. PMID: 21330250 Review.
203 results